Luciana Borio: Difference between revisions

Luciana Borio
Luciana Borio
Born	Rio de Janeiro, Brazil
Academic background
Education	George Washington University (MD)
Academic work
Discipline	Medicine; Public health
Sub-discipline	Infectious diseases; Biodefense; Health security

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Inline

Latest revision as of 18:34, 26 June 2024

Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel.^[1] She previously served as director for Medical and Biodefense Preparedness at the National Security Council,^[2] acting chief scientist of the U.S. Food and Drug Administration (FDA),^[3] assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats.^[4] She is known for her work advancing clinical trials,^[5]^[6] the development of medical countermeasures for health emergencies,^[7] and the public health responses to Ebola and Zika outbreaks.^[8]

On November 9, 2020, U.S. president-elect Joe Biden named Borio to be one of the 13 members of his COVID-19 Advisory Board.^[9]

Early life and education

Borio obtained her MD in 1996 from George Washington University. She completed residency in 1999 in internal medicine at the Weill Cornell Medical Center and subsequently completed a combined fellowship in infectious diseases at Johns Hopkins University and critical care medicine at the National Institutes of Health. Borio continues to practice medicine at Johns Hopkins Hospital.^[10]

Career

Borio is an infectious disease physician.^[11] Prior to joining FDA's Center for Biologics Evaluation and Research in 2008, Borio was senior associate at the UPMC Center for Health Security and assistant professor of medicine at the University of Pittsburgh (2003–2008). Borio served at the United States Department of Health and Human Services as an advisor on biodefense programs (2001 to 2008), where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response.^[12] Before leaving her role as assistant commissioner of FDA, she approved a partnership in infectious disease research with the Bill & Melinda Gates Foundation.^[13]

In 2020, Borio was appointed by the Council on Foreign Relations to serve on its Independent Task Force on Improving Pandemic Preparedness, co-chaired by Sylvia Mathews Burwell and Frances Townsend.^[14]

In 2020, an honoree of the Great Immigrants Award named by Carnegie Corporation of New York.^[15]

Other activities

Codagenix, Member of the Scientific Advisory Board^[16]
Goldman Sachs, Consultant^[17]

References

^ Borio, Luciana; Gottlieb, Scott (January 28, 2020). "Act now to prevent an American epidemic". Wall Street Journal. Retrieved 2020-01-30.
^ "Key Global Health Positions and Officials in the U.S. Government". Kaiser Family Foundation. Retrieved 2018-07-28.
^ "Examining the U.S. Public Health Response to the Zika Virus: U.S. Food and Drug Administration Testimony before U.S. House of Representatives". U.S. Food and Drug Administration. Retrieved 2018-07-28.
^ "Meet Luciana Borio, M.D., Acting Chief Scientist". Food and Drug Administration. 2015-04-06. Archived from the original on 2016-03-29.{{cite web}}: CS1 maint: unfit URL (link)
^ "Luciana Borio: FDA's Role in Increasing Clinical Trial Diversity". U.S. Food and Drug Administration. Retrieved 2018-07-28.
^ "You may hold the cure for the next epidemic". TEDxUSU. Retrieved 2018-07-28.
^ "Borio interview". Johns Hopkins University Center for Health Security. Retrieved 2018-07-28.
^ September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”
^ Mucha, Sarah (November 9, 2020). "Biden transition team announces coronavirus advisers, including whistleblower Rick Bright". CNN. Retrieved 9 November 2020.
^ "Luciana Borio, MD". WebMD. Retrieved 2013-10-04.
^ Gamboa, Suzanne (November 9, 2020). "Two Latino physicians and disease experts are part of Biden's Covid-19 task force". NBC News. Retrieved 2020-11-10.
^ "Dr. Luciana Borio: Faces Behind MCMi". Food and Drug Administration. 2013-07-12. Archived from the original on 2013-10-04. Retrieved 2013-10-04.{{cite web}}: CS1 maint: unfit URL (link)
^ "Mou 225-17-019". FDA. 3 November 2018.
^ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.
^ "Luciana Borio". Carnegie Corporation of New York. Retrieved June 26, 2024.
^ Luciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020.
^ Luciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020.

External links

Appearances on C-SPAN
Luciana Borio Outlines the Evolving Role of the FDA in Developing Medical Countermeasures upmchealthsecurity.org

[1] Borio, Luciana; Gottlieb, Scott (January 28, 2020). "Act now to prevent an American epidemic". Wall Street Journal. Retrieved 2020-01-30.

[2] "Key Global Health Positions and Officials in the U.S. Government". Kaiser Family Foundation. Retrieved 2018-07-28.

[3] "Examining the U.S. Public Health Response to the Zika Virus: U.S. Food and Drug Administration Testimony before U.S. House of Representatives". U.S. Food and Drug Administration. Retrieved 2018-07-28.

[4] "Meet Luciana Borio, M.D., Acting Chief Scientist". Food and Drug Administration. 2015-04-06. Archived from the original on 2016-03-29.{{cite web}}: CS1 maint: unfit URL (link)

[5] "Luciana Borio: FDA's Role in Increasing Clinical Trial Diversity". U.S. Food and Drug Administration. Retrieved 2018-07-28.

[6] "You may hold the cure for the next epidemic". TEDxUSU. Retrieved 2018-07-28.

[7] "Borio interview". Johns Hopkins University Center for Health Security. Retrieved 2018-07-28.

[8] September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”

[9] Mucha, Sarah (November 9, 2020). "Biden transition team announces coronavirus advisers, including whistleblower Rick Bright". CNN. Retrieved 9 November 2020.

[10] "Luciana Borio, MD". WebMD. Retrieved 2013-10-04.

[11] Gamboa, Suzanne (November 9, 2020). "Two Latino physicians and disease experts are part of Biden's Covid-19 task force". NBC News. Retrieved 2020-11-10.

[12] "Dr. Luciana Borio: Faces Behind MCMi". Food and Drug Administration. 2013-07-12. Archived from the original on 2013-10-04. Retrieved 2013-10-04.{{cite web}}: CS1 maint: unfit URL (link)

[13] "Mou 225-17-019". FDA. 3 November 2018.

[14] Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.

[15] "Luciana Borio". Carnegie Corporation of New York. Retrieved June 26, 2024.

[16] Luciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020.

[17] Luciana Borio, Senior Fellow for Global Health Council on Foreign Relations, October 2020.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

@@ Line 1: / Line 1: @@
-{{short description|Physician and public health administrator}}
+{{Short description|Brazilian-American physician and public health administrator}}
-{{Infobox officeholder
+{{Infobox academic
-|name        = Luciana Borio
+| name                = Luciana Borio
-|image       = File:Luciana_Borio_official_portrait.jpg
+| image               = File:Luciana_Borio_official_portrait.jpg
+| birth_place         = [[Rio de Janeiro]], [[Brazil]]
-|office      = National Security Council Director for Medical and Biodefense Preparedness
+| death_date          =
-|president   = [[Donald Trump]]
+| death_place         =
-|term_start  = 2017
+| education  = [[George Washington University]] ([[Doctor of Medicine|MD]])
-|term_end    = 2019
+|discipline=[[Medicine]]<br>[[Public health]]|sub_discipline=[[Infectious diseases]]<br>[[Biodefense]]<br>[[Health security]]}}
-|predecessor = [[Andrew Garrett (scientist)|Andrew Garrett]]
+'''Luciana Borio''' is a [[Brazilian-American]] infectious disease physician and public health administrator. She is a vice president at [[In-Q-Tel]].<ref>{{cite news|url=https://www.wsj.com/articles/act-now-to-prevent-an-american-epidemic-11580255335|title=Act now to prevent an American epidemic|first1=Luciana|last1=Borio|first2=Scott|last2=Gottlieb|date=January 28, 2020|accessdate=2020-01-30|work=Wall Street Journal}}</ref> She previously served as director for Medical and Biodefense Preparedness at the [[United States National Security Council|National Security Council]],<ref>{{cite web |url=https://www.kff.org/global-health-policy/fact-sheet/key-u-s-government-agency-positions-and-officials-in-global-health-policy-related-areas/ |title=Key Global Health Positions and Officials in the U.S. Government |publisher=Kaiser Family Foundation |accessdate=2018-07-28}}</ref> acting chief scientist of the [[Food and Drug Administration|U.S. Food and Drug Administration]] (FDA),<ref>{{cite web |url=https://www.fda.gov/NewsEvents/Testimony/ucm489176.htm |title=Examining the U.S. Public Health Response to the Zika Virus: U.S. Food and Drug Administration Testimony before U.S. House of Representatives |publisher=U.S. Food and Drug Administration |accessdate=2018-07-28}}</ref> assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats.<ref>{{Cite web |date=2015-04-06 |title=Meet Luciana Borio, M.D., Acting Chief Scientist |url=http://www.fda.gov/AboutFDA/CentersOffices/ucm286183.htm |url-status=usurped |archive-url=https://web.archive.org/web/20160329222232/http://www.fda.gov/AboutFDA/CentersOffices/ucm286183.htm |archive-date=2016-03-29 |website=[[Food and Drug Administration]]}}</ref> She is known for her work advancing clinical trials,<ref>{{cite web |url=https://www.youtube.com/watch?v=wSjjS7M5jts |title=Luciana Borio: FDA's Role in Increasing Clinical Trial Diversity |publisher=U.S. Food and Drug Administration |accessdate=2018-07-28}}</ref><ref>{{cite web |url=https://www.youtube.com/watch?v=IBRK2lEXaOg&t=866s |title=You may hold the cure for the next epidemic |publisher=TEDxUSU |accessdate=2018-07-28}}</ref> the development of medical countermeasures for health emergencies,<ref>{{cite web |url=https://www.youtube.com/watch?v=M9ha3xHlUpg&t=2s |title=Borio interview |publisher=Johns Hopkins University Center for Health Security |accessdate=2018-07-28}}</ref> and the public health responses to [[Ebola]] and [[Zika]] outbreaks.<ref>September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”</ref>
-|successor   =
-|office1      = Acting Chief Scientist of the FDA
+On November 9, 2020, [[President-elect of the United States|U.S. president-elect]] [[Joe Biden]] named Borio to be one of the 13 members of his [[COVID-19 Advisory Board]].<ref>{{cite news|url=https://www.cnn.com/2020/11/09/politics/biden-coronavirus-advisers-experts-rick-bright/index.html|title=Biden transition team announces coronavirus advisers, including whistleblower Rick Bright|last=Mucha|first=Sarah|date=November 9, 2020|work=CNN|accessdate=9 November 2020}}</ref>
-|president1   = [[Barack Obama]] and [[Donald Trump]]
-|term_start1  = 2015
-|term_end1    = 2017
-|predecessor1 = [[Stephen Ostroff]]
-|successor1   = [[Denise Hinton]]
-|office2      = Assistant Commissioner of FDA for Counterterrorism Policy
-|president2   = [[Barack Obama]]
-|term_start2  = 2010
-|term_end2    = 2017
-|predecessor2 = RADM [[Boris Lushniak]]
-|successor2   = RADM [[Carmen Maher]]
-|birth_place = [[Rio de Janeiro]], [[Brazil]]
-|death_date  =
-|death_place =
-|alma_mater  = [[George Washington University]]
-}}
-'''Luciana Borio''' is a Brazilian-American physician and medical/public health administrator. She is a vice president at [[In-Q-Tel]].<ref>{{cite news|url=https://www.wsj.com/articles/act-now-to-prevent-an-american-epidemic-11580255335|title=Act now to prevent an American epidemic|first=Luciana|last=Borio|first2=Scott|last2=Gottlieb|date=January 28, 2020|accessdate=2020-01-30|work=Wall Street Journal}}</ref> She previously served as Director for Medical and Biodefense Preparedness at the [[United States National Security Council|National Security Council]],<ref>{{cite web |url=https://www.kff.org/global-health-policy/fact-sheet/key-u-s-government-agency-positions-and-officials-in-global-health-policy-related-areas/ |title=Key Global Health Positions and Officials in the U.S. Government |publisher=Kaiser Family Foundation |accessdate=2018-07-28}}</ref> Acting Chief Scientist of the [[Food and Drug Administration|U.S. Food and Drug Administration]] (FDA),<ref>{{cite web |url=https://www.fda.gov/NewsEvents/Testimony/ucm489176.htm |title=Examining the U.S. Public Health Response to the Zika Virus: U.S. Food and Drug Administration Testimony before U.S. House of Representatives |publisher=U.S. Food and Drug Administration |accessdate=2018-07-28}}</ref> Assistant Commissioner for Counterterrorism Policy of the FDA, and Director of FDA's Office of Counterterrorism and Emerging Threats.{{dl|date=July 2020}}<ref>{{dl|date=July 2020}}{{cite web |url=https://www.fda.gov/AboutFDA/CentersOffices/ucm286183.htm |title=Meet Luciana Borio, M.D., Assistant Commissioner for Counterterrorism Policy |publisher=U.S. Food and Drug Administration |accessdate=2013-10-04}}</ref> She is known for her work advancing clinical trials,<ref>{{cite web |url=https://www.youtube.com/watch?v=wSjjS7M5jts |title=Luciana Borio: FDA’s Role in Increasing Clinical Trial Diversity |publisher=U.S. Food and Drug Administration |accessdate=2018-07-28}}</ref><ref>{{cite web |url=https://www.youtube.com/watch?v=IBRK2lEXaOg&t=866s |title=You may hold the cure for the next epidemic |publisher=TEDxUSU |accessdate=2018-07-28}}</ref> the development of medical countermeasures for health emergencies,<ref>{{cite web |url=https://www.youtube.com/watch?v=M9ha3xHlUpg&t=2s |title=Borio interview |publisher=Johns Hopkins University Center for Health Security |accessdate=2018-07-28}}</ref> and the public health responses to [[Ebola]] and [[Zika]] outbreaks.<ref>September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”</ref>
 == Early life and education ==
@@ Line 33: / Line 17: @@
 == Career ==
-Prior to joining FDA's [[Center for Biologics Evaluation and Research]] in 2008, Borio was senior associate at the [[UPMC Center for Health Security]] and assistant professor of medicine at the [[University of Pittsburgh]] (2003-2008). Borio served at the [[United States Department of Health and Human Services]] as an advisor on biodefense programs (2001 to 2008), where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response.<ref>{{cite web |url=https://www.fda.gov/EmergencyPreparedness/MedicalCountermeasures/ucm327479.htm |title=Dr. Luciana Borio: Faces Behind MCMi |publisher=U.S. Food and Drug Administration |accessdate=2013-10-04}}</ref>
+Borio is an infectious disease physician.<ref>{{Cite web|last=Gamboa|first=Suzanne|date=November 9, 2020|title=Two Latino physicians and disease experts are part of Biden's Covid-19 task force|url=https://www.nbcnews.com/news/latino/two-latino-physicians-disease-experts-are-part-biden-s-covid-n1247165|archive-url=|archive-date=|access-date=2020-11-10|website=NBC News|language=en}}</ref> Prior to joining FDA's [[Center for Biologics Evaluation and Research]] in 2008, Borio was senior associate at the [[UPMC Center for Health Security]] and assistant professor of medicine at the [[University of Pittsburgh]] (2003–2008). Borio served at the [[United States Department of Health and Human Services]] as an advisor on biodefense programs (2001 to 2008), where she implemented and managed mathematical modeling projects to assess the health effects of bioterrorism on civilians and to inform medical countermeasures procurement activities for the Office of Preparedness and Response.<ref>{{cite web |date=2013-07-12 |title=Dr. Luciana Borio: Faces Behind MCMi |url=https://www.fda.gov/EmergencyPreparedness/MedicalCountermeasures/ucm327479.htm |url-status=usurped |archive-url=https://web.archive.org/web/20131004220452/http://www.fda.gov/EmergencyPreparedness/MedicalCountermeasures/ucm327479.htm |archive-date=2013-10-04 |accessdate=2013-10-04 |website=[[Food and Drug Administration]]}}</ref> Before leaving her role as assistant commissioner of FDA, she approved a partnership in infectious disease research with the [[Bill & Melinda Gates Foundation]].<ref>{{Cite journal|url=https://www.fda.gov/about-fda/non-profit-and-other-mous/mou-225-17-019|title = Mou 225-17-019|journal = FDA|date = 3 November 2018}}</ref>
-In 2020, Borio was appointed by the [[Council on Foreign Relations]] to serve on its  Independent Task Force on Improving Pandemic Preparedness, co-chaired by [[Sylvia Mathews Burwell]] and [[Frances Fragos Townsend]].<ref>[https://www.cfr.org/report/pandemic-preparedness-lessons-COVID-19/ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19] [[Council on Foreign Relations]], October 2020.</ref>
+In 2020, Borio was appointed by the [[Council on Foreign Relations]] to serve on its Independent Task Force on Improving Pandemic Preparedness, co-chaired by [[Sylvia Mathews Burwell]] and [[Frances Townsend]].<ref>[https://www.cfr.org/report/pandemic-preparedness-lessons-COVID-19/ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19] [[Council on Foreign Relations]], October 2020.</ref>
+In 2020, an honoree of the [[Great Immigrants Award]] named by [[Carnegie Corporation of New York]].<ref>{{Cite web |title=Luciana Borio |url=https://www.carnegie.org/awards/honoree/luciana-borio/ |access-date=June 26, 2024 |website=Carnegie Corporation of New York}}</ref>
-On November 9, 2020, [[President-elect of the United States|President-elect]] [[Joe Biden]] named Borio to be one of the 13 members of his coronavirus task force.<ref>{{cite news|url=https://www.cnn.com/2020/11/09/politics/biden-coronavirus-advisers-experts-rick-bright/index.html|title=Biden transition team announces coronavirus advisers, including whistleblower Rick Bright|last=Mucha|first=Sarah|date=November 9, 2020|work=CNN|accessdate=9 November 2020}}</ref>
 == Other activities ==
@@ Line 49: / Line 33: @@
 {{commons category}}
 {{wikiquote}}
-*{{C-SPAN|Luciana Borio}}
+*{{C-SPAN|77552}}
 * [https://web.archive.org/web/20131005010428/http://www.upmchealthsecurity.org/website/resources/multimedia/2012_behind_the_scenes/01_borio.html Luciana Borio Outlines the Evolving Role of the FDA in Developing Medical Countermeasures] upmchealthsecurity.org
@@ Line 55: / Line 39: @@
 {{DEFAULTSORT:Borio, Luciana}}
-[[Category:George Washington University Medical School alumni]]
+[[Category:George Washington University School of Medicine & Health Sciences alumni]]
 [[Category:Living people]]
-[[Category:People from Rio de Janeiro (city)]]
+[[Category:Physicians from Rio de Janeiro (city)]]
 [[Category:American public health doctors]]
 [[Category:Brazilian emigrants to the United States]]
@@ Line 68: / Line 52: @@
 [[Category:21st-century American physicians]]
 [[Category:21st-century American women physicians]]
+[[Category:COVID-19 researchers]]
+[[Category:Hispanic and Latino American women physicians]]
+[[Category:Members of the National Academy of Medicine]]
+[[Category:Women public health doctors]]